The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Infection accounted for the first cause of death in patients after liver transplantation, and 2 / 3 of the cause of death was fungal infections. The investigators group early found that T cell subsets playing a role of inducing immune tolerance were significantly increased in vivo of liver transplantation patients with aspergillus infection, which may be a kind of Treg cells expressing IL-17. To explore the immune tolerance mechanism induced by the immune balance cells is important to liver transplantation patients for improving efficacy and reducing the mortality. Therefore, the investigators are going to get the blood sample and liver tissue of the liver transplantation patients before and after treatment of aspergillus infection, flow cytometry analysis of blood T cell subsets, Cytometric Bead Array to detect changes in blood cytokines, laser capture microdissection to obtain liver biopsies of inflammatory cells in portal area and further for analysis of T cell subsets and protein. And the investigators are also to investigate the characteristics of CCR6 + CD4 + FOXP3 + Treg cell clones secreting IL-17 and the capacity of which suppressing conventional T cell proliferation. This study may find new methods, such as certain types of T cell subsets or cytokines for the treatment of liver transplant patients, which not only to anti-rejection but also to reduce fungal infection.
| Condition |
|---|
|
Liver Transplantation Aspergillus Interleukin-17 Treg Cell Immune Tolerance |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
Eligibility| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
liver transplantation patients with aspergillus infection or without aspergillus infection
Inclusion Criteria:
Liver transplantation patients
Exclusion Criteria:
Psychopath
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Shanghai First People's Hospital |
| ClinicalTrials.gov Identifier: | NCT01117077 History of Changes |
| Other Study ID Numbers: | 10ZR1423900 |
| Study First Received: | May 4, 2010 |
| Last Updated: | May 4, 2010 |
| Health Authority: | China: Ministry of Health |
Keywords provided by Shanghai Jiao Tong University School of Medicine:
|
liver transplantation aspergillus infection interleukin-17 Treg cell immune tolerance |
ClinicalTrials.gov processed this record on May 19, 2013